US-based medical device company Neural Analytics has launched its Lucid M1 Transcranial Doppler Ultrasound System.

The company has also pledged support to the Society of Vascular and Interventional Neurology's (SVIN) Mission 2020, a mission to improve stroke care by significantly increasing stroke treatments for eligible patients and reducing global stroke disability.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Neural Analytics co-founder and chief scientific officer Robert Hamilton said: “We are pleased to support SVIN on this important initiative to improve stroke treatment worldwide and help reduce the disability associated with this condition.

"A critical component for effective stroke treatment is determining an accurate diagnosis as quickly as possible."

“A critical component for effective stroke treatment is determining an accurate diagnosis as quickly as possible in settings inside and outside the hospital.

"Neural Analytics is developing new and improved portable tools to help expedite the determination and treatment of patients suffering from these brain diseases.”

See Also:

Cleared by the US Food and Drug Administration (FDA), the Lucid system is a portable brain monitoring system to measure cerebral blood flow velocities within the head and neck.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The system uses a type of ultrasound called Trans Cranial Doppler to non-invasively analyse the brain’s blood vessels from outside the body.

The non-invasive analysis can be performed in the physician’s office, and enables diagnosis of brain disorders, without the need for additional, more invasive tests.

The Lucid system is operated by a battery and has been designed as a medical grade tablet that can be easily moved in a range of settings that require the rapid assessment of blood flow in the brain to accelerate treatment.

Image: Lucid M1 Transcranial Doppler Ultrasound System. Photo: courtesy of Business Wire.